Non-preferred NSAIDs and COX-2 inhibitors by all Sub-ICB Locations
Why it matters: There have been a number of concerns about the safety of a number of anti-inflammatory drugs, including COX-2 inhibitors and some 'traditional' NSAIDS, for their effects on the stomach, kidneys and the risk of blood clots. NICE CKD recommends that in patients with ischaemic heart disease, cerebrovascular disease, or peripheral arterial disease ibuprofen (up to 1200mg per day) and naproxen (up to 1000mg) should be prescribed first-line and COX-2 inhibitors, diclofenac, and high-dose ibuprofen are contraindicated
Description: Number of prescription items for all NSAIDs excluding ibuprofen and naproxen as a percentage of the total items for all NSAIDs
Explore:
Tagged as: Cardiovascular system, Standard, NICE, Pain, Safety (or browse all measures)
Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.
View measure for NHS England combined →
Fetching data...